Clinical evolution

(Image: Getty/Radachynskyi)

Recro spins out Baudax to boost CDMO focus

By Vassia Barba

Recro Pharma announces the separation of its acute care business to launch Baudax Bio as a developer of products, including non-opioid analgesics, to concentrate on its CDMO business.

(Image: Getty/chombosan)

FT PHARMACEUTICAL & BIOTECHNOLOGY CONFERENCE

The danger of ‘going too far’ with AI

By Vassia Barba

Industry experts dealing with AI services should be showing both devotion to the possibilities opened and skepticism at the same time, says ICON exec.

(Image: Getty/maxsattana)

GE Healthcare sets up UK biotech R&D lab

By Vassia Barba

GE Healthcare opens lab space to provide developers with access to protein and cell analysis technologies to encourage networking and partnering on R&D services.

Follow us

Products

View more

Webinars